Follow
Yecheskel Schneider
Yecheskel Schneider
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis
JD Feuerstein, KL Isaacs, Y Schneider, SM Siddique, Y Falck-Ytter, ...
Gastroenterology 158 (5), 1450-1461, 2020
4942020
Cost effectiveness of gastric cancer screening according to race and ethnicity
M Saumoy, Y Schneider, N Shen, M Kahaleh, RZ Sharaiha, SC Shah
Gastroenterology 155 (3), 648-660, 2018
1312018
Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis
V Jacob, C Crawford, S Cohen-Mekelburg, M Viladomiu, GG Putzel, ...
Inflammatory bowel diseases 23 (6), 903-911, 2017
1152017
A single-operator learning curve analysis for the endoscopic sleeve gastroplasty
M Saumoy, Y Schneider, XK Zhou, A Shukla, M Kahaleh, L Aronne, ...
Gastrointestinal endoscopy 87 (2), 442-447, 2018
782018
Association between cirrhosis and stroke in a nationally representative cohort
NS Parikh, BB Navi, Y Schneider, A Jesudian, H Kamel
JAMA neurology 74 (8), 927-932, 2017
602017
Perianal fistulas in patients with Crohn’s disease, part 1: current medical management
SL Gold, S Cohen-Mekelburg, Y Schneider, A Steinlauf
Gastroenterology & Hepatology 14 (8), 470, 2018
292018
Discharge disposition after stroke in patients with liver disease
NS Parikh, AE Merkler, Y Schneider, BB Navi, H Kamel
Stroke 48 (2), 476-478, 2017
252017
Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics
NT Shen, JA Leff, Y Schneider, CV Crawford, A Maw, B Bosworth, ...
Open forum infectious diseases 4 (3), ofx148, 2017
222017
Cost effectiveness of early insertion of transjugular intrahepatic portosystemic shunts for recurrent ascites
NT Shen, Y Schneider, SE Congly, RE Rosenblatt, Y Namn, BE Fortune, ...
Clinical Gastroenterology and Hepatology 16 (9), 1503-1510. e3, 2018
212018
Perianal fistulas in patients with Crohn’s disease, Part 2: Surgical, endoscopic, and future therapies
SL Gold, S Cohen-Mekelburg, Y Schneider, A Steinlauf
Gastroenterology & hepatology 14 (9), 521, 2018
192018
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma
S Kambhampati, M Saumoy, Y Schneider, S Serrao, P Solaimani, ...
Blood, The Journal of the American Society of Hematology 140 (19), 2024-2036, 2022
182022
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma
S Kambhampati, M Saumoy, Y Schneider, S Pak, LE Budde, MG Mei, ...
Blood, The Journal of the American Society of Hematology 140 (25), 2697-2708, 2022
172022
Optical coherence tomography (OCT) prior to peroral endoscopic myotomy (POEM) reduces procedural time and bleeding: a multicenter international collaborative study
AP Desai, A Tyberg, P Kedia, MS Smith, G Martinez, F Zamarripa, ...
Surgical endoscopy 30, 5126-5133, 2016
162016
Premedication use in preventing acute infliximab infusion reactions in patients with inflammatory bowel disease: a single center cohort study
SL Gold, S Cohen-Mekelburg, Y Schneider, N Shen, A Faggen, A Rupert, ...
Inflammatory Bowel Diseases 23 (10), 1882-1889, 2017
152017
A cost-effectiveness analysis for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis in the United States
NR Thiruvengadam, M Saumoy, Y Schneider, S Attala, J Triggs, P Lee, ...
Clinical Gastroenterology and Hepatology 20 (1), 216-226. e42, 2022
142022
Biosimilars in inflammatory bowel disease
AM Buchner, Y Schneider, GR Lichtenstein
Official journal of the American College of Gastroenterology| ACG 116 (1), 45-56, 2021
142021
Advances in the diagnosis and management of colonic dysplasia in patients with inflammatory bowel disease
S Cohen-Mekelburg, Y Schneider, S Gold, E Scherl, A Steinlauf
Gastroenterology & Hepatology 13 (6), 357, 2017
142017
Threshold analysis of the cost-effectiveness of endoscopic ultrasound in patients at high risk for pancreatic ductal adenocarcinoma
S Kumar, M Saumoy, A Oh, Y Schneider, RE Brand, A Chak, GG Ginsberg, ...
Pancreas 50 (6), 807-814, 2021
132021
Delays in initiating post-operative prophylactic biologic therapy are common among Crohn’s disease patients
S Cohen-Mekelburg, S Gold, Y Schneider, M Dennis, C Oromendia, ...
Digestive Diseases and Sciences 64, 196-203, 2019
132019
Risk of early colorectal cancers needs to be considered in inflammatory bowel disease care
S Cohen-Mekelburg, Y Schneider, S Gold, G Ghosh, R Rosenblatt, ...
Digestive diseases and sciences 64, 2273-2279, 2019
122019
The system can't perform the operation now. Try again later.
Articles 1–20